Filtered By:
Specialty: Cardiology
Infectious Disease: COVID-19
This page shows you your search results in order of date. This is page number 7.
Order by Relevance | Date
Total 396 results found since Jan 2013.
The impact of first wave of the SARS-CoV-2 2019 pandemic in Poland on characteristics and outcomes of patients hospitalized due to stable coronary artery disease
CONCLUSIONS: The SARS-CoV-2 2019 pandemic affected the characteristics and hospitalization course of stable angina patients hospitalized following the first wave. The hospitalization outcome was similar in the analyzed time intervals. The higher prevalence of comorbidities raises concern regarding upcoming years.PMID:36200545 | DOI:10.5603/CJ.a2022.0094
Source: Cardiology Journal - October 6, 2022 Category: Cardiology Authors: Justyna Jankowska-Sanetra Krzysztof Sanetra Marta Konopko Monika Kutowicz Magdalena Synak Krzysztof Milewski Pawe ł Kaźmierczak Łukasz Kołtowski Piotr P Buszman Source Type: research
Predictors of Intensive Care Unit Admission in Patients with Confirmed Coronavirus Disease 2019: A Cross-Sectional Study
CONCLUSION: A high index of suspicion for ICU admission should be maintained in patients with positive clinical and laboratory predictive factors.PMID:36117577 | PMC:PMC9445874 | DOI:10.30476/IJMS.2021.89916.2068
Source: Atherosclerosis - September 19, 2022 Category: Cardiology Authors: Naeimehossadat Asmarian Farid Zand Parvin Delavari Vahid Khaloo Zahra Esmaeilinezhad Golnar Sabetian Yaldasadat Moeini Mohsen Savaie Fatemeh Javaherforooshzadeh Farhad Soltani Farid Yousefi Ebrahim Heidari Sardabi Maryam Haddadzadeh Shoushtari Anoush Dehn Source Type: research
Anticoagulation and Antiplatelet Therapy for Prevention of Venous and Arterial Thrombotic Events in Critically Ill Patients with COVID-19: COVID-PACT
Conclusions: In critically-ill patients with COVID-19, full-dose anticoagulation, but not clopidogrel, reduced thrombotic complications with an increase in bleeding, driven primarily by transfusions in hemodynamically stable patients, and no apparent excess in mortality.PMID:36036760 | DOI:10.1161/CIRCULATIONAHA.122.061533
Source: Circulation - August 29, 2022 Category: Cardiology Authors: Erin A Bohula David D Berg Mathew S Lopes Jean M Connors Iljal Babar Christopher F Barnett Sunit-Preet Chaudhry Amit Chopra Wilson Ginete Michael H Ieong Jason N Katz Edy Y Kim Julia F Kuder Emilio Mazza Dalton McLean Jarrod M Mosier Ari Moskowitz Sabina Source Type: research
Evaluation of Cerebrovascular Reactivity and Vessel-Wall Imaging in Patients With Prior COVID-19: A Prospective Case-Control MRI Study
Conclusion: SARS-CoV2 infection is associated with chronic CVR impairment. The mechanistic basis is unknown from this study. Clinical Impact: Future studies are needed to determine the clinical implications arising from SARS-CoV2-associated CVR impairment.PMID:36000667 | DOI:10.2214/AJR.22.28267
Source: Atherosclerosis - August 24, 2022 Category: Cardiology Authors: Andrew L Callen Jody Tanabe Ashesh A Thaker Rebecca Pollard Brian Sauer William Jones Jack Pattee Brandon Steach Vincent Timpone Source Type: research
Remote ischaemic conditioning: defining critical criteria for success —report from the 11th Hatter Cardiovascular Workshop
Discussion points included how to adapt preclinical animal studies to mirror the patient presenting with an acute myocardial infarction, as well as how to refine patient selection in clinical studies to account for co-morbidities and ongoing therapy. These latter scenarios can modify cytoprotective signalling and need to be taken into account to allow for a more robust outcome when powered appropriately. The workshop also discussed the pote ntial for RIC in other disease settings including ischaemic stroke, cardio-oncology and COVID-19. The workshop, therefore, put forward specific classifications which could help identify...
Source: Basic Research in Cardiology - August 15, 2022 Category: Cardiology Source Type: research
Impact of cardiometabolic multimorbidity and ethnicity on cardiovascular/renal complications in patients with COVID-19
Conclusions
In hospitalised patients with COVID-19, cardiovascular complications or death impacts just under half of all patients, with the highest risk in those of South Asian or Black ethnicity and in patients with cardiometabolic multimorbidity.
Source: Heart - July 13, 2022 Category: Cardiology Authors: Norris, T., Razieh, C., Zaccardi, F., Yates, T., Islam, N., Gillies, C. L., Chudasama, Y. V., Rowlands, A. V., Davies, M. J., McCann, G. P., Banerjee, A., Lam, C. S. P., Docherty, A. B., Openshaw, P. J., Baillie, J. K., Semple, M. G., Lawson, C. A., Khunt Tags: Open access Cardiac risk factors and prevention Source Type: research
What Is or What Is Not a Risk Factor for Arterial Hypertension? Not Hamlet, but Medical Students Answer That Question
Int J Environ Res Public Health. 2022 Jul 5;19(13):8206. doi: 10.3390/ijerph19138206.ABSTRACTHypertension is a leading cause of cardiovascular disease and premature death worldwide. The most important method of preventing hypertension is social awareness of its causes. An important role in educating society about hypertension is played by medical personnel. The study involved 327 students of medicine representing all years of study. The study used a proprietary questionnaire containing test questions about knowledge of the causes of hypertension (classical and non-classical factors), as well as questionable and false risk ...
Source: Atherosclerosis - July 9, 2022 Category: Cardiology Authors: Tomasz Sobierajski Stanis ław Surma Monika Roma ńczyk Krzysztof Łabuzek Krzysztof J Filipiak Suzanne Oparil Source Type: research
